image

The best stocks to buy since 1993

Our latest issue will be released in 7 days, don't miss out!

Microlise - ARR up 11% to £47.2m

February 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SAAS
  • Price:
  • 125p
The steep decline in the small cap index since it touched a high at the end of 2021 has produced a sequence of new issues that failed to take off. In some cases, there is nothing wrong with the companies being floated. For instance, I covered Ashtead Technology (AT.; 672p), which opened up at a small discount to its IPO price but has since gone on  to quadruple. Another where there is absolutely nothing wrong is Microlise, which I covered in September ‘21 shortly after it listed but told readers to hold off at 181p and wait for a better Buy opportunity. It’s here now at 130p and the company confirmed it is trading well ahead of market expectations. The shares look a steal. As chief executive Nadeem Raza and finance director  Willi ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe